eCOA, eSource & Clinical Trials Market

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Global Trends

    1.3. Market Dynamics

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Global Pharmaceutical Outlook

4. Key Market Trends

5. Key Success Factors

    5.1. Global Adoption Pattern

    5.2. Key Deals and Contracts

6. Key Inclusions

    6.1. Clinical Trial – Patient Journey

    6.2. Digitization in Clinical Trials

    6.3. Paper-based vs. EDC data flow

    6.4. Return on Investment

    6.5. Traditional Process versus eCOA Integration Process

    6.6. Evolution of RTSM Technology and Terminology

    6.7. Global Market – Regulations

7. Global Spending on Spending (in US$ Mn) Analysis 2018-2022 and Forecast, 2023-2033

    7.1. Historical Spending (US$ Mn) Analysis, 2018-2022

    7.2. Current and Future Spending (US$ Mn) Projections, 2023-2033

        7.2.1. Y-o-Y Growth Trend Analysis

8. Market Background

    8.1. Macro-Economic Factors

        8.1.1. Increasing R&D Expenditure

        8.1.2. Increasing number of Biotechnology Companies

        8.1.3. Rise in ICT Spending

    8.2. Forecast Factors - Relevance & Impact

        8.2.1. Increase in R&D Spending

        8.2.2. Rise in Healthcare IT Spending

        8.2.3. Increase in Number of Clinical Trials

        8.2.4. Increasing Cost of Clinical Trials

    8.3. Market Dynamics

        8.3.1. Drivers

        8.3.2. Restraints

        8.3.3. Opportunity Analysis

9. Global Spending 2018-2022 and Forecast 2023-2033, by Solution Type

    9.1. Introduction / Key Findings

    9.2. Historical Spending (US$ Mn) Analysis By Solution Type, 2018-2022

    9.3. Current and Future Spending (US$ Mn) Analysis and Forecast By Solution Type, 2023-2033

        9.3.1. eCOA (Electronic clinical Outcome assessment)

            9.3.1.1. ePROs (Patient Reported Outcomes)

            9.3.1.2. ClinROs (Clinician Reported Outcomes)

            9.3.1.3. ObsROs (Observer reported Outcomes)

            9.3.1.4. PerfOs (Performance Outcomes)

        9.3.2. eSource

        9.3.3. Clinical Trials Solutions

            9.3.3.1. Clinical Data Management Systems (CDMS)

            9.3.3.2. Clinical Trial Management Systems (CTMS)

            9.3.3.3. Randomization and Trial Supply Management Systems (RTMS)

            9.3.3.4. Trail Planning and Safety Solutions

        9.3.4. Electronic Data Capture (EDC)

    9.4. Market Attractiveness Analysis By Solution Type

10. Global Spending Analysis 2018-2022 and Forecast 2023-2033, by Deployment

    10.1. Introduction / Key Findings

    10.2. Historical Spending (US$ Mn) Analysis By Deployment, 2018-2022

    10.3. Current and Future Spending (US$ Mn) Analysis and Forecast By Deployment, 2023-2033

        10.3.1. Licensed Enterprise (On Premise)

        10.3.2. Cloud-based (SaaS)

    10.4. Market Attractiveness Analysis By Deployment

11. Global Spending Analysis 2018-2022 and Forecast 2023-2033, by End User

    11.1. Introduction / Key Findings

    11.2. Historical Spending (US$ Mn) Analysis By End User, 2018-2022

    11.3. Current and Future Spending (US$ Mn) Analysis and Forecast By End User, 2023-2033

        11.3.1. Contract Research Organizations

        11.3.2. Hospitals & Other Healthcare Facilities

        11.3.3. Pharmaceutical/Biotechnology/Medical Devices Companies

        11.3.4. Educational & Research Institutes

    11.4. Market Attractiveness Analysis By End User

12. Global Spending Analysis 2018-2022 and Forecast 2023-2033, by Region

    12.1. Introduction

    12.2. Historical Spending (US$ Mn) Analysis By Region, 2018-2022

    12.3. Current and Future Spending (US$ Mn) Analysis and Forecast By Region, 2023-2033

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Middle East and Africa (MEA)

        12.3.5. East Asia

        12.3.6. South Asia

        12.3.7. Oceania

    12.4. Market Attractiveness Analysis By Region

13. North America Spending Analysis 2018-2022 and Forecast 2023-2033

    13.1. Introduction

    13.2. Historical Spending (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    13.3. Spending (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Solution Type

        13.3.3. By Deployment

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

    13.5. Drivers and Restraints - Impact Analysis

14. Latin America Spending Analysis 2018-2022 and Forecast 2023-2033

    14.1. Introduction

    14.2. Historical Spending (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    14.3. Spending (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Rest of Latin America

        14.3.2. By Solution Type

        14.3.3. By Deployment

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints - Impact Analysis

15. Europe Spending Analysis 2018-2022 and Forecast 2023-2033

    15.1. Introduction

    15.2. Historical Spending (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    15.3. Spending (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Solution Type

        15.3.3. By Deployment

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints - Impact Analysis

16. South Asia Spending Analysis 2018-2022 and Forecast 2023-2033

    16.1. Introduction

    16.2. Historical Spending (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    16.3. Spending (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Solution Type

        16.3.3. By Deployment

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Drivers and Restraints - Impact Analysis

17. East Asia Spending Analysis 2018-2022 and Forecast 2023-2033

    17.1. Introduction

    17.2. Historical Spending (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    17.3. Spending (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Solution Type

        17.3.3. By Deployment

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

    17.5. Drivers and Restraints - Impact Analysis

18. Oceania Spending Analysis 2018-2022 and Forecast 2023-2033

    18.1. Introduction

    18.2. Historical Spending (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    18.3. Spending (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Solution Type

        18.3.3. By Deployment

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

    18.5. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Spending Analysis 2018-2022 and Forecast 2023-2033

    19.1. Introduction

    19.2. Historical Spending (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    19.3. Spending (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Turkey

            19.3.1.3. Northern Africa

            19.3.1.4. South Africa

            19.3.1.5. Rest of Middle East and Africa

        19.3.2. By Solution Type

        19.3.3. By Deployment

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

    19.5. Drivers and Restraints - Impact Analysis

20. Emerging Countries Spending Analysis 2018-2022 and Forecast 2023-2033

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

    20.2. China Market Analysis

        20.2.1. Introduction

        20.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.2.2.1. By Solution Type

            20.2.2.2. By Deployment

            20.2.2.3. By End User

    20.3. India Market Analysis

        20.3.1. Introduction

        20.3.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.3.2.1. By Solution Type

            20.3.2.2. By Deployment

            20.3.2.3. By End User

    20.4. Brazil Market Analysis

        20.4.1. Introduction

        20.4.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.4.2.1. By Solution Type

            20.4.2.2. By Deployment

            20.4.2.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Key Development Analysis

    22.3. Competition Deep Dive

        22.3.1. OpenClinica, LLC

            22.3.1.1. Overview

            22.3.1.2. Solution Portfolio

            22.3.1.3. Analyst Commentary

        22.3.2. CRF Health, Inc.

            22.3.2.1. Overview

            22.3.2.2. Solution Portfolio

            22.3.2.3. Analyst Commentary

        22.3.3. ERT Clinical

            22.3.3.1. Overview

            22.3.3.2. Solution Portfolio

            22.3.3.3. Analyst Commentary

        22.3.4. Medidata Solutions, Inc.

            22.3.4.1. Overview

            22.3.4.2. Solution Portfolio

            22.3.4.3. Analyst Commentary

        22.3.5. ArisGlobal LLC

            22.3.5.1. Overview

            22.3.5.2. Solution Portfolio

            22.3.5.3. Analyst Commentary

        22.3.6. Health Diary, Inc.

            22.3.6.1. Overview

            22.3.6.2. Solution Portfolio

            22.3.6.3. Analyst Commentary

        22.3.7. ICON plc

            22.3.7.1. Overview

            22.3.7.2. Solution Portfolio

            22.3.7.3. Analyst Commentary

        22.3.8. PAREXEL International Corporation

            22.3.8.1. Overview

            22.3.8.2. Solution Portfolio

            22.3.8.3. Analyst Commentary

        22.3.9. OmniComm Systems, Inc.

            22.3.9.1. Overview

            22.3.9.2. Solution Portfolio

            22.3.9.3. Analyst Commentary

        22.3.10. PAREXEL International Corporation

            22.3.10.1. Overview

            22.3.10.2. Solution Portfolio

            22.3.10.3. Analyst Commentary

        22.3.11. Medrio, Inc.

            22.3.11.1. Overview

            22.3.11.2. Solution Portfolio

            22.3.11.3. Analyst Commentary

        22.3.12. PAREXEL International Corporation

            22.3.12.1. Overview

            22.3.12.2. Solution Portfolio

            22.3.12.3. Analyst Commentary

        22.3.13. Medable

            22.3.13.1. Overview

            22.3.13.2. Solution Portfolio

            22.3.13.3. Analyst Commentary

        22.3.14. PAREXEL International Corporation

            22.3.14.1. Overview

            22.3.14.2. Solution Portfolio

            22.3.14.3. Analyst Commentary

        22.3.15. Oracle Corp

            22.3.15.1. Overview

            22.3.15.2. Solution Portfolio

            22.3.15.3. Analyst Commentary

        22.3.16. PAREXEL International Corporation

            22.3.16.1. Overview

            22.3.16.2. Solution Portfolio

            22.3.16.3. Analyst Commentary

        22.3.17. Medpace Holdings, Inc.

            22.3.17.1. Overview

            22.3.17.2. Solution Portfolio

            22.3.17.3. Analyst Commentary

        22.3.18. PAREXEL International Corporation

            22.3.18.1. Overview

            22.3.18.2. Solution Portfolio

            22.3.18.3. Analyst Commentary

        22.3.19. Covance, Inc.

            22.3.19.1. Overview

            22.3.19.2. Solution Portfolio

            22.3.19.3. Analyst Commentary

        22.3.20. PAREXEL International Corporation

            22.3.20.1. Overview

            22.3.20.2. Solution Portfolio

            22.3.20.3. Analyst Commentary

        22.3.21. Bio-Optronics, Inc.

            22.3.21.1. Overview

            22.3.21.2. Solution Portfolio

            22.3.21.3. Analyst Commentary

        22.3.22. PAREXEL International Corporation

            22.3.22.1. Overview

            22.3.22.2. Solution Portfolio

            22.3.22.3. Analyst Commentary

23. Assumptions and Acronyms Used

24. Research Methodology

List Of Table

Table 01: Global Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 02: Global Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 03: Global Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 04: Global Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Region

Table 05: North America Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 06: North America Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 07: North America Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 08: North America Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 09: Latin America Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 10: Latin America Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 11: Latin America Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 12: Latin America Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 13: Europe Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 14: Europe Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 15: Europe Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 16: Europe Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 17: South Asia Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 18: South Asia Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 19: South Asia Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 20: South Asia Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 21: East Asia Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 22: East Asia Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 23: East Asia Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 24: East Asia Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 25: Oceania Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 26: Oceania Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 27: Oceania Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 28: Oceania Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 29: MEA Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 30: MEA Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 31: MEA Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 32: MEA Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 33: China Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 34: China Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 35: China Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 36: India Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 37: India Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 38: India Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

Table 39: Brazil Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Solution Type

Table 40: Brazil Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Deployment

Table 41: Brazil Spending (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User

List Of Figures

Figure 01: Spending Share, 2023 & 2028

Figure 02: Number of FDA approved pharmaceuticals (2018-2022)

Figure 03: Global Spending Analysis (US$ Mn), 2018-2022

Figure 04: Global Spending Forecast (US$ Mn), 2023-2033

Figure 05: Spending (US$ Mn) Analysis, by eCOA segment, 2018–2022

Figure 06: Spending Y-o-Y Growth (%), by eCOA segment, 2022–2033

Figure 07: Spending (US$ Mn) Analysis, by eSource segment, 2018–2022

Figure 08: Software Spending Y-o-Y Growth (%), by eSource segment, 2022–2033

Figure 09: Spending (US$ Mn) Analysis, by segment, 2018–2022

Figure 10: Spending Y-o-Y Growth (%), by segment, 2022–2033

Figure 11: Spending (US$ Mn) Analysis, by EDC segment, 2018–2022

Figure 12: Software Spending Y-o-Y Growth (%), by EDC segment, 2022–2033

Figure 13: Spending (US$ Mn) Analysis, by Licensed Enterprise (On Premise) segment, 2018–2022

Figure 14: Spending Y-o-Y Growth (%), by Licensed Enterprise (On Premise) segment, 2022–2033

Figure 15: Spending (US$ Mn) Analysis, by Cloud Based (SaaS) segment, 2018–2022

Figure 16: Software Spending Y-o-Y Growth (%), by Cloud Based (SaaS) segment, 2022–2033

Figure 17: Spending (US$ Mn) Analysis, by Contract Research Organizations segment, 2018–2022

Figure 18: Spending Y-o-Y Growth (%), by Contract Research Organizations segment, 2022–2033

Figure 19: Spending (US$ Mn) Analysis, by Hospitals & Other Healthcare Facilities segment, 2018–2022

Figure 20: Software Spending Y-o-Y Growth (%), by Hospitals & Other Healthcare Facilities segment, 2022–2033

Figure 21: Spending (US$ Mn) Analysis, by Pharmaceutical/Biotechnology/Medical Device Companies segment, 2018–2022

Figure 22: Spending Y-o-Y Growth (%), by Pharmaceutical/Biotechnology/Medical Device Companies segment, 2022–2033

Figure 23: Spending (US$ Mn) Analysis, by Educational & Research Institutes segment, 2018–2022

Figure 24: Software Spending Y-o-Y Growth (%), by Educational & Research Institutes segment, 2022–2033

Figure 25: Global Market Attractiveness Analysis, By Solution Type

Figure 26: Global Market Attractiveness Analysis, By Deployment

Figure 27: Global Market Attractiveness Analysis, By End User

Figure 28: Global Market Attractiveness Analysis, By Region

Figure 29: North America spending share, by Solution Type (2022)

Figure 30: North America Spending, Snapshot

Figure 31: North America Spending (US$ Mn), 2018–2022

Figure 32: North America Spending (US$) & Y-o-Y Growth (%), 2023–2033

Figure 33: North America Market Attractiveness Analysis, By Solution Type

Figure 34: North America Market Attractiveness Analysis, By Deployment

Figure 35: North America Market Attractiveness Analysis, By End User

Figure 36: North America Market Attractiveness Analysis, By Country

Figure 37: Latin America spending share, by Solution Type (2022)

Figure 38: Latin America Spending, Snapshot

Figure 39: Latin America Spending (US$ Mn), 2018–2022

Figure 40: Latin America Spending (US$) & Y-o-Y Growth (%), 2023–2033

Figure 41: Latin America Market Attractiveness Analysis, By Solution Type

Figure 42: Latin America Market Attractiveness Analysis, By Deployment

Figure 43: Latin America Market Attractiveness Analysis, By End User

Figure 44: Latin America Market Attractiveness Analysis, By Country

Figure 45: Europe spending share, by Solution Type (2022)

Figure 46: Europe Spending, Snapshot

Figure 47: Europe Spending (US$ Mn), 2018–2022

Figure 48: Europe Spending (US$) & Y-o-Y Growth (%), 2023–2033

Figure 49: Europe Market Attractiveness Analysis, By Solution Type

Figure 50: Europe Market Attractiveness Analysis, By Deployment

Figure 51: Europe Market Attractiveness Analysis, By End User

Figure 52: Europe Market Attractiveness Analysis, By Country

Figure 53: South Asia spending share, by Solution Type (2022)

Figure 54: South Asia Spending, Snapshot

Figure 55: South Asia Spending (US$ Mn), 2018–2022

Figure 56: South Asia Spending (US$) & Y-o-Y Growth (%), 2023–2033

Figure 57: South Asia Market Attractiveness Analysis, By Solution Type

Figure 58: South Asia Market Attractiveness Analysis, By Deployment

Figure 59: South Asia Market Attractiveness Analysis, By End User

Figure 60: South Asia Market Attractiveness Analysis, By Country

Figure 61: East Asia spending share, by Solution Type (2022)

Figure 62: East Asia Spending, Snapshot

Figure 63: East Asia Spending (US$ Mn), 2018–2022

Figure 64: East Asia Spending (US$) & Y-o-Y Growth (%), 2023–2033

Figure 65: East Asia Market Attractiveness Analysis, By Solution Type

Figure 66: East Asia Market Attractiveness Analysis, By Deployment

Figure 67: East Asia Market Attractiveness Analysis, By End User

Figure 68: East Asia Market Attractiveness Analysis, By Country

Figure 69: Oceania spending share, by Solution Type (2022)

Figure 70: Oceania Spending, Snapshot

Figure 71: Oceania Spending (US$ Mn), 2018–2022

Figure 72: Oceania Spending (US$) & Y-o-Y Growth (%), 2023–2033

Figure 73: Oceania Market Attractiveness Analysis, By Solution Type

Figure 74: Oceania Market Attractiveness Analysis, By Deployment

Figure 75: Oceania Market Attractiveness Analysis, By End User

Figure 76: Oceania Market Attractiveness Analysis, By Country

Figure 77: MEA spending share, by Solution Type (2022)

Figure 78: MEA Spending, Snapshot

Figure 79: MEA Spending (US$ Mn), 2018–2022

Figure 80: MEA Spending (US$) & Y-o-Y Growth (%), 2023–2033

Figure 81: MEA Market Attractiveness Analysis, By Solution Type

Figure 82: MEA Market Attractiveness Analysis, By Deployment

Figure 83: MEA Market Attractiveness Analysis, By End User

Figure 84: MEA Market Attractiveness Analysis, By Country

Figure 85: Emerging Countries Spending (US$ Mn), 2018–2022

Figure 86: Emerging Countries Spending (US$) & Y-o-Y Growth (%), 2023–2033